CoChat

Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme.

Gutova, Margarita, Najbauer, Joseph, Y. Chen, Mike, M. Potter, Philip, U. Kim, Seung, S. Aboody, Karen · 2010 · Current Stem Cell Research & Therapy

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Neural stem cells (NSCs) have been investigated in preclinical models as delivery vehicles for therapeutic genes for treatment of tumors in the central nervous system and other organs. Melanoma at early stages is effectively treated with surgery and radiotherapy, however metastatic disease is almost universally fatal, thus novel therapeutic approaches are needed. We studied the use of HB1.F3.CD therapeutic NSCs, a well-characterized clonal cell line derived from human fetal telencephalon, for their potential of secreting prodrug-activating enzyme. HB1.F3.CD cells were transduced by adenovirus encoding rabbit carboxylesterase (rCE), which converts CPT-11 into SN-38, a potent topoisomerase 1 inhibitor. In vitro cell migration assays revealed robust migration of NSCs to conditioned media from melanoma cells. Cytokine profiles showed that IL-6, IL-8, MCP-1 and TIMP-2, known chemoattractants for stem cells, were highly expressed by melanoma cells. Exposure of melanoma cells to conditioned media from the HB1.F3.CD.rCE cells in the presence of CPT-11 increased the tumor cell-killing effect by approximately 100-fold when compared to CPT-11 alone. Our data demonstrate the rational for NSC-based enzyme/prodrug therapeutic approach to target metastatic melanoma. Future experiments will evaluate the therapeutic efficacy of NSC-mediated melanoma therapy in animal models, which will provide the basis for targeted therapy in patients with advanced melanoma.

Overview

Integrity signals

Registry

Crossref · 10.2174/157488810791824421

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

Cited by 28

Metadata

Authors
Gutova, M., Najbauer, J., Y. Chen, M., M. Potter, P., U. Kim, S., & S. Aboody, K.
Affiliations
City Of Hope National Medical Center (US)
Venue
Current Stem Cell Research & Therapy
Published
2010-09-01
Volume
5
Issue
3
Pages
273-276
ISSN
1574-888X (ISSN-L)
OpenAlex
W2102698959
Cited by
28
References
0
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 5
FWCI
3.81
Type
journal article
Language
en
Open access
closed
Locations
  • Current Stem Cell Research & Therapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Stop Cancer
  • St. Jude Children's Research Hospital
  • Rosalinde and Arthur Gilbert Foundation
  • American Lebanese Syrian Associated Charities
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
neural stem cells, melanoma, carboxylesterase, irinotecan, SN-38, prodrug activation, adenoviral gene transfer, stem cell migration, chemokines, metastatic melanoma, topoisomerase I inhibitor, targeted therapy
MeSH terms
Irinotecan, Animals, Antineoplastic Agents, Phytogenic, Camptothecin, Cell Movement, Enzyme Inhibitors, Humans, Melanoma, Neurons, Rabbits, Stem Cells, Cytokines, Carboxylesterase, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. https://app.cochat.ai/papers/10.2174/157488810791824421
The paper
Gutova, M., Najbauer, J., Y. Chen, M., M. Potter, P., U. Kim, S., & S. Aboody, K. (2010). Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. Current Stem Cell Research & Therapy. https://doi.org/10.2174/157488810791824421

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.